Pegfilgrastim biosimilar (Qilu Pharmaceuticals)

聚乙二醇化重组人粒细胞刺激因子（齐鲁制药）

Report date: 2022/01/14 13:23:58

Base Information

Drug NamePegfilgrastim biosimilar (Qilu Pharmaceuticals)

Drug Alias NamePegylated Recombinant Human Granulocyte Colony-stimulating Factor Injection (Qilu Pharmaceuticals)聚乙二醇化非格司亭生物仿制药（齐鲁制药）聚乙二醇化非格司亭生物类似药（齐鲁制药）聚乙二醇化重组人粒细胞刺激因子注射液（齐鲁制药）新瑞白 +[6]

ClassificationBiologics > BiosimilarBiologics > Protein drugs > Recombinant protein > Recombinant cytokines

Mechanisms of ActionColony stimulating factor 3 receptor agonists

TargetsColony stimulating factor 3 receptor

Therapy Area/IndicationsNeutropenia

Global Approved IndicationsNeutropenia

Approved Indications in ChinaNeutropenia

Original Approved Country/TerritoryMainland China

Original Approved Date2015/08/08

Country/TerritoryMainland China

CombinationsNo

Global Highest StatusApproved

Highest Status in ChinaApproved

Originator CompaniesQilu Pharmaceutical Co Ltd

China Registration ClassN/A

Develop Information

Active CompaniesQilu Pharmaceutical Co Ltd

Inactive CompaniesN/A

Active IndicationsNeutropenia

Inactive IndicationsN/A

Other Information

ATC CodeL03AA13